• 85 Commercial Road, Level 2, Burnet Institute

    3004 Melbourne

    Australia

  • Department of Infectious Diseases, The Alfred and Central Clinical School, Monash University

    Australia

20092019
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Based on the background of my clinical experience as an Infectious Diseases Physician and Clinical Microbiologist, I am currently working on a PhD research project in the area of antimicrobial PK/PD in-vitro modelling. I am passionate about tackling the problems of Antimicrobial Resistance and optimising the treatment of complex infection syndromes in vulnerable patients.

External positions

Council, Australasian Society for Infectious Diseases (ASID)

20182019

Infectious Diseases Physician, Alfred Health

2017 → …

Research area keywords

  • Antimicrobial Pharmacology
  • Antimicrobial Resistance
  • Infectious Diseases

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2019

Research Output 2009 2019

2 Citations (Scopus)

Evolution of daptomycin resistance in coagulase-negative staphylococci involves mutations of the essential two-component regulator WALKR

Jiang, J-H., Dexter, C., Cameron, D. R., Monk, I. R., Baines, S. L., Abbott, I. J., Spelman, D. W., Kostoulias, X., Nethercott, C., Howden, B. P. & Peleg, A. Y., 1 Mar 2019, In : Antimicrobial Agents and Chemotherapy. 63, 3, 10 p., e01926-18.

Research output: Contribution to journalArticleResearchpeer-review

In vivo acquisition of fosfomycin resistance in Escherichia coli by fosA transmission from commensal flora

Doesschate, T. T., Abbott, I. J., Willems, R. J. L., Top, J., Rogers, M. R. C., Bonten, M. M. & Paganelli, F. L., 1 Dec 2019, In : Journal of Antimicrobial Chemotherapy. 74, 12, p. 3630-3632 3 p., dkz380.

Research output: Contribution to journalArticleOtherpeer-review

Open Access
File
2 Citations (Scopus)

Nitrofurantoin and fosfomycin for resistant urinary tract infections: Old drugs for emerging problems

Gardiner, B. J., Stewardson, A. J., Abbott, I. J. & Peleg, A. Y., 1 Feb 2019, In : Australian Prescriber. 42, 1, p. 14-19 6 p.

Research output: Contribution to journalArticleOtherpeer-review

Open Access
File
1 Citation (Scopus)

Urinary antibacterial activity of fosfomycin and nitrofurantoin at registered dosages in healthy volunteers

Wijma, R. A., Huttner, A., van Dun, S., Kloezen, W., Abbott, I. J., Muller, A. E., Koch, B. C. P. & Mouton, J. W., 1 Oct 2019, In : International Journal of Antimicrobial Agents. 54, 4, p. 435-441 7 p.

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)

Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model

Abbott, I. J., Meletiadis, J., Belghanch, I., Wijma, R. A., Kanioura, L., Roberts, J. A., Peleg, A. Y. & Mouton, J. W., 1 Mar 2018, In : Journal of Antimicrobial Chemotherapy. 73, 3, p. 709-719 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File